UCLA in the News June 4, 2024
Highlights from KCAL-TV, CNN, LAist and others.
Stay updated with breaking news from Steven Raman. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Minimally invasive transurethral ultrasound ablation provides disease control without side effects
Minimally invasive transurethral ultrasound ablation provides disease control without side effects. Minimally invasive transurethral ultrasound ablation provides disease control without side effects.
For the treatment of localized prostate cancer, in-bore, MRI-guided TULSA results in favorable outcomes at five years.
Researchers at the UCLA Health Jonsson Comprehensive Cancer Center have received a five-year, $3 million grant from the National Cancer Institute to identify novel cancer biomarkers and develop AI that can detect and predict aggressive prostate cancer to help avoid unnecessary treatments and their associated negative side effects.